Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Cash from Operations (2016 - 2021)

Historic Cash from Operations for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q4 2021 value amounting to -$2.5 million.

  • Phio Pharmaceuticals' Cash from Operations rose 579.49% to -$2.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.9 million, marking a year-over-year decrease of 3471.94%. This contributed to the annual value of -$7.1 million for FY2024, which is 3383.57% up from last year.
  • As of Q4 2021, Phio Pharmaceuticals' Cash from Operations stood at -$2.5 million, which was up 579.49% from -$2.9 million recorded in Q3 2021.
  • In the past 5 years, Phio Pharmaceuticals' Cash from Operations registered a high of -$1.7 million during Q4 2018, and its lowest value of -$3.3 million during Q1 2021.
  • In the last 5 years, Phio Pharmaceuticals' Cash from Operations had a median value of -$2.2 million in 2017 and averaged -$2.3 million.
  • In the last 5 years, Phio Pharmaceuticals' Cash from Operations plummeted by 6042.27% in 2017 and then skyrocketed by 3186.85% in 2018.
  • Over the past 5 years, Phio Pharmaceuticals' Cash from Operations (Quarter) stood at -$2.2 million in 2017, then rose by 20.67% to -$1.7 million in 2018, then crashed by 45.82% to -$2.5 million in 2019, then fell by 3.02% to -$2.6 million in 2020, then increased by 5.79% to -$2.5 million in 2021.
  • Its last three reported values are -$2.5 million in Q4 2021, -$2.9 million for Q3 2021, and -$3.3 million during Q2 2021.